Jordi Mata-Fink
Vorstandsvorsitzender bei Gate Bioscience, Inc.
Profil
Jordi Mata-Fink is the founder of Cygnal Therapeutics, Inc. (founded in 2017), Rubius Therapeutics, Inc. (founded in 2014), and Gate Bioscience, Inc. (founded in 2021).
He held the title of Director of Research at Rubius Therapeutics, Inc. Dr. Mata-Fink's current job is at Flagship Pioneering, where he has been a Principal since 2013.
In terms of education, Dr. Mata-Fink attended Stanford University for undergraduate and graduate studies and obtained a doctorate degree from the Massachusetts Institute of Technology.
Aktive Positionen von Jordi Mata-Fink
| Unternehmen | Position | Beginn |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private-Equity-Analyst | 01.01.2013 |
Gate Bioscience, Inc.
 Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Vorstandsvorsitzender | 01.01.2021 |
Ehemalige bekannte Positionen von Jordi Mata-Fink
| Unternehmen | Position | Ende |
|---|---|---|
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Gründer | - |
| RUBIUS THERAPEUTICS | Gründer | - |
Ausbildung von Jordi Mata-Fink
| Stanford University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Gate Bioscience, Inc.
Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Health Technology |
